| Detected | Trial | Change |
|---|---|---|
| 2026-05-30 | NCT06972446 A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis |
Trial sites reduced: 96 -> 88 locations |
| 2026-05-29 | NCT06548542 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to… |
Primary endpoint(s) modified |
| 2026-05-29 | NCT06548542 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to… |
date change Primary completion pushed: 2027-12 -> 2030-01 |
| 2026-05-29 | NCT06548542 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to… |
date change Completion pushed: 2028-08 -> 2030-01 |
| 2026-05-29 | NCT06468228 A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT06972446 A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis |
Trial sites expanded: 84 -> 94 locations |
| 2026-05-19 | NCT06972446 A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis |
Trial sites expanded: 71 -> 83 locations |
| 2026-05-14 | NCT06972446 A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis |
Trial sites reduced: 79 -> 71 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06468228 | A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent… | Hidradenitis Suppurativa | Active, Not Recruiting |
| Phase 2 | |||
| NCT06548542 | Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to… | Crohn's Disease | Recruiting |
| NCT06972446 | A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis | Rheumatoid Arthritis | Recruiting |
| NCT05139602 | A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in… | Hidradenitis Suppurativa | Active, Not Recruiting |
| NCT06718101 | A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in… | Atopic Dermatitis | Active, Not Recruiting |